R03CC03 - Terbutaline |
Not porphyrinogenic |
NP |
Rationale
Rather low dose In large part not metabolised. No indication for CYP-interaction.
Chemical description
Adrenergic bronchodilator for systemic treatment (solution for injection or infusion 0.5 mg/mL) used in bronchospasm of various origin. Metabolised by sulfation, about 60% excreted in urine in unchanged form.
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | French List
Centre Français des Porphyries
|
|
Tradenames